This resolution expresses strong support for designating September 2025 as National Prostate Cancer Awareness Month , recognizing the significant impact of prostate cancer on men's health. It highlights that prostate cancer is the most commonly diagnosed non-skin cancer and the second-leading cause of cancer-related deaths among men in the United States, affecting 1 in 8 men in their lifetimes. The resolution emphasizes that early detection through screening methods is critical, as survival rates are nearly 100 percent when diagnosed at localized or regional stages, contrasting sharply with much lower survival rates for metastatic cases. The Senate declares that steps should be taken to raise awareness about screening and treatment, encourage research to improve detection, treatment, and discover a cure, and continue to consider ways to enhance access to and quality of healthcare services for prostate cancer. It also calls upon the people of the United States, interest groups, and affected persons to actively promote awareness and observe National Prostate Cancer Awareness Month with appropriate activities. This initiative underscores the importance of education and ongoing research, supported by significant federal appropriations, to combat the devastating effects of the disease.
Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent.
Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S6959; text: CR S6958-6959)
Introduced in Senate
Passed/agreed to in Senate: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent.
Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent.
Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S6959; text: CR S6958-6959)
Introduced in Senate
Passed/agreed to in Senate: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent.
CancerCommemorative events and holidaysHealth care coverage and accessHealth care qualityHealth promotion and preventive careMedical researchMedical tests and diagnostic methodsResearch administration and funding
A resolution expressing support for the designation of September 2025 as "National Prostate Cancer Awareness Month".
USA119th CongressSRES-436| Senate
| Updated: 10/6/2025
This resolution expresses strong support for designating September 2025 as National Prostate Cancer Awareness Month , recognizing the significant impact of prostate cancer on men's health. It highlights that prostate cancer is the most commonly diagnosed non-skin cancer and the second-leading cause of cancer-related deaths among men in the United States, affecting 1 in 8 men in their lifetimes. The resolution emphasizes that early detection through screening methods is critical, as survival rates are nearly 100 percent when diagnosed at localized or regional stages, contrasting sharply with much lower survival rates for metastatic cases. The Senate declares that steps should be taken to raise awareness about screening and treatment, encourage research to improve detection, treatment, and discover a cure, and continue to consider ways to enhance access to and quality of healthcare services for prostate cancer. It also calls upon the people of the United States, interest groups, and affected persons to actively promote awareness and observe National Prostate Cancer Awareness Month with appropriate activities. This initiative underscores the importance of education and ongoing research, supported by significant federal appropriations, to combat the devastating effects of the disease.
Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent.
Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S6959; text: CR S6958-6959)
Introduced in Senate
Passed/agreed to in Senate: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent.
Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent.
Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S6959; text: CR S6958-6959)
Introduced in Senate
Passed/agreed to in Senate: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent.
CancerCommemorative events and holidaysHealth care coverage and accessHealth care qualityHealth promotion and preventive careMedical researchMedical tests and diagnostic methodsResearch administration and funding